TAYROID STIMULATING HORMONE EXTRACTED FROM HUMAN PLACENTA
F Akasu+4 more
openalex +2 more sources
Some observations on a case of twin abortion with double placenta prævia and a remarkable condition of cervix [PDF]
R. J. Kinkead
openalex +1 more source
Abstract Objective The aim of this study was to compare the cost of a strategy initially resorting to intrauterine balloon tamponade versus a strategy initially resorting to uterine artery embolization in the management pathway of persistent postpartum hemorrhage.
Lisanne R. Bonsen+9 more
wiley +1 more source
Co-culture of JEG-3, BeWo and syncBeWo cell lines with adrenal H295R cell line : an alternative model for examining endocrine and metabolic properties of the fetoplacental unit [PDF]
Drwal, Eliza+2 more
core +1 more source
Establishment and Maintenance of Feline Pregnancy-A Comprehensive Review. [PDF]
Schäfer-Somi S.
europepmc +1 more source
FIGO guideline on liver disease and pregnancy
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana+24 more
wiley +1 more source
Sex-differentiated placental methylation and gene expression regulation has implications for neonatal traits and adult diseases. [PDF]
Tekola-Ayele F+7 more
europepmc +1 more source
Studies on the Estrogen-sensitive Enzyme System from Placenta
Vincent P. Hollander+2 more
openalex +1 more source
The impact and management of hyperemesis gravidarum: Current and future perspectives
Abstract Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting in pregnancy affecting around 1%–3% of pregnancies worldwide and is the most common reason for hospital admission in early pregnancy. HG can have lasting consequences for both pregnant individuals and their offspring.
L. M. van der Minnen+4 more
wiley +1 more source
Risk factors for emergent delivery before 36 weeks among pregnant women with placenta accreta spectrum disorder. [PDF]
Phetrat N+3 more
europepmc +1 more source